Provides development information of cell products for corneal endothelium treatment. One leading cause of vison loss due to corneal endothelial decompensation is Fuchs endothelial corneal dystrophy (FECD), which has a prevalence of 4% in the Caucasian population over 40 years of age. The usual treatment for FECD is corneal transplantation, but this procedure has associated problems, especially a shortage of donor corneas. Othe...
Provides development information of cell products for corneal endothelium treatment. One leading cause of vison loss due to corneal endothelial decompensation is Fuchs endothelial corneal dystrophy (FECD), which has a prevalence of 4% in the Caucasian population over 40 years of age. The usual treatment for FECD is corneal transplantation, but this procedure has associated problems, especially a shortage of donor corneas. Other issues include graft failure (at both early and late phases) and the difficulty of the surgical transplantation procedure.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.